The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 23, 2016

Filed:

Jul. 28, 2014
Applicant:

Italfarmaco S.p.a., Milan, IT;

Inventors:

Valentina Saccone, Naples, IT;

Silvia Consalvi, Ciampino, IT;

Pier Lorenzo Puri, Rome, IT;

Paolo Mascagni, Villasanta, IT;

Assignee:

ITALFARMACO S.P.A., Milan, IT;

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/325 (2006.01); A61K 9/00 (2006.01); A61K 31/167 (2006.01); A61K 31/573 (2006.01); A61K 45/06 (2006.01); A61K 31/58 (2006.01);
U.S. Cl.
CPC ...
A61K 31/325 (2013.01); A61K 9/0095 (2013.01); A61K 31/167 (2013.01); A61K 31/573 (2013.01); A61K 31/58 (2013.01); A61K 45/06 (2013.01);
Abstract

The present invention relates to a method for treating muscular dystrophy which comprises administering diethyl-[6-(4-hydroxycarbamoyl-phenyl-carbamoyloxy-methyl)-naphthalen-2-yl-methyl]-ammonium chloride or other pharmaceutically acceptable salts and/or solvates thereof to a patient in need of such a treatment. The invention further relates to a method for treating muscular dystrophy which comprises administering diethyl-[6-(4-hydroxycarbamoyl-phenyl-carbamoyloxy-methyl)-naphthalen-2-yl-methyl]-ammonium chloride or other pharmaceutically acceptable salts and/or solvates thereof in combination with one or more additional anti-inflammatory active agents to a patient in need of such a treatment.


Find Patent Forward Citations

Loading…